
Centene Reports $253 Million Loss Amid Health Insurer Cost Struggles
Health insurer Centene reported a $253 million loss in its second quarter as the provider of government-subsidized benefits struggles to manage costs of its health plan members.
The $253 million loss, or 51 cents a share, compares to a $1.1 billion in net income, or $2.16 a share, in the second quarter of last year, Centene disclosed Friday in its quarterly earnings report. Centene said premium and service revenues increased 18% to $42.5 billion from $36 billion in the year ago period.
Centene, which has 28 million health plan subscribers, is seeing rising costs among health plan members in all three government-subsidized benefits it helps manage: Medicaid, Medicare Advantage and individual coverage under the Affordable Care Act, also known as Obamacare.
"We are disappointed by our second quarter results, but we have a clear understanding of the trends that have impacted our performance and are working with urgency and focus to restore our earnings trajectory," Centene Chief Executive Officer Sarah M. London said in a statement accompanying the company's earnings report. "Despite the shifting landscape, we believe that the staying power of Medicaid, Medicare and the Individual Marketplace is as strong as it has ever been. Centene has significantly fortified our platform in service of these programs over the last three years, and as we move forward, we are focused on continuing to adapt with the market to deliver meaningful value to our members, our stakeholders and our shareholders over the long term."
Centene, which planned to reveal its 2025 profit forecast during a call with analysts Friday morning, pulled its financial guidance earlier this month, citing an independent firm's analysis showing patients it provides health benefits for were sicker and needed more healthcare services than anticipated.
On Friday, Centene said its health benefits ratio, which is the percentage of premium revenue that goes toward medical costs, jumped to 93% for the second quarter of 2025, compared to 87.6% in the comparable period in 2024.
'The (health benefits ratio) increase was primarily driven by a reduction in the company's net 2025 Marketplace risk adjustment revenue transfer estimate, increased Marketplace medical costs, higher medical costs in Medicaid driven primarily by behavioral health, home health and high-cost drugs, and an increase to the 2025 Medicare Advantage premium deficiency reserve based on the progression of earnings during the year (with higher earnings at the beginning of the year and lower at the end of the year, given cost sharing progression),' Centene said in its second quarter earnings report.
Centene's cost struggles are only the latest among a parade of health insurance companies that have struggled in the last two years to control costs of subscribers in plans subsidized by the government.
Just last week, Elevance Health, which sells Blue Cross and Blue Shield plans in 14 states, lower its profit forecast for the rest of 2025 due to rising costs in its Medicaid plans and individual policies it sells under the Affordable Care Act. In addition, Molina Healthcare lowered its earnings guidance for the rest of the year in the face of cost pressures in all three of the government-subsidized health insurance programs it helps manage: Medicaid, Medicare Advantage and individual coverage under the ACA, also known as Obamacare.
And in May, UnitedHealth suspended its financial outlook for the rest of the year and replaced its top executive as the parent of UnitedHealthcare grapples with rising healthcare costs in its Medicare Advantage business. Medicare Advantage plans contract with the federal government to provide health benefits to seniors.
Medicare Advantage plans also contributed to struggles last year for Humana and CVS Health, which elevated a new chief executive in part to help gain control of its struggling Aetna health insurance business. CVS is also exiting the individual health insurance business, leaving about 1 million Aetna members in 17 states looking for new coverage in 2026.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
17 minutes ago
- Yahoo
Wes Streeting rules out pay rises for striking resident doctors saying they have 'squandered goodwill'
Resident doctors have "squandered the considerable goodwill" they had with the government by going on strike, Health Secretary Wes Streeting has told them. The medics - formerly known as junior doctors - finished a five-day strike over pay on Wednesday morning. The group were awarded a close to 30% raise last year but say they want more in an attempt to bring their pay back in line with what they had in 2008. Mr Streeting previously said he would not negotiate further on pay but would consider taking steps on working conditions. He has reiterated that stance - and continued to put pressure on negotiations to start again on the government's terms. The British Medical Association Resident Doctors Committee, which represents the doctors, have not ruled out further action. In a letter sent today to the co-chairs of the committee, Mr Streeting thanked them for an invitation to "get back to the negotiating table" - but added the barb that it was "ironic because I never left". "I am ready to continue the conversation from where you left it," he added. He went on to say the strikes was "deeply disappointing and entirely unnecessary" - adding that there were "seemingly promising discussions" about improving doctors' working lives. Read more: 'We cannot move on pay' Mr Streeting criticised the committee, saying they "rushed to strike". His letter added: "The consequences of your strike action have been a detrimental impact on patients, your members, your colleagues and the NHS, which might have been worse were it not for the considerable efforts of NHS leaders and front-line staff who stepped up. "Your action has also been self-defeating, because you have squandered the considerable goodwill you had with me and this government. I cannot in good conscience let patients, or other NHS staff, pay the price for the costs of your decision." The health secretary said he wanted to "reset the relationship" between the government and young doctors following the previous industrial action. Mr Streeting went on to say he is "serious about improving working conditions" but has been clear "we cannot move on pay". "This government is prepared to negotiate on areas related to your conditions at work, career progression and tangible measures which would put money in your members' pockets," he added. 👉Listen to Politics At Sam And Anne's on your podcast app👈 Mr Streeting concluded: "I was critical of my predecessors when they closed the door to the Junior Doctors Committee. "My door remains open to the hope that we can still build the partnership with resident doctors I aspired to when I came in a year ago and, in that spirit, I am happy to meet with you early next week."


Washington Post
20 minutes ago
- Washington Post
Deals completed for six of the eight cricket teams in The Hundred competition
LONDON — The sales of stakes in six of the eight teams in The Hundred competition have been completed, the England and Wales Cricket Board said Wednesday. The eight partnerships are valued at 975 million pounds (around $1.3 billion), with 500 million pounds invested back into the English and Welsh cricket ecosystem, including 50 million pounds for grassroots cricket.
Yahoo
24 minutes ago
- Yahoo
Humana Boosts Outlook on Lower-Than-Expected Medicare Advantage Membership Drop
Key Takeaways Humana raised its full-year outlook as it anticipates a smaller decline in Medicare Advantage membership than originally expected. The health insurance provider also sees a bigger gain in patient growth at its CenterWell Primary Care centers. Humana beat second-quarter earnings and revenue (HUM) shares took off Wednesday when the health insurer boosted its guidance as it sees fewer losses of Medicare Advantage customers than previously thought. The company now anticipates full-year adjusted earnings per share (EPS) of about $17.00, up from its previous outlook of approximately $16.25. It expects revenue to be at least $128 billion, versus the earlier forecast of $126 billion to $128 billion. Humana estimated Medicare Advantage membership will drop as many as 500,000 members, lower than its former prediction of approximately 550,000. In addition, it sees its CenterWell Primary Care medical treatment centers for senior citizens to have a net patient growth of 50,000 to 70,000. Its prior guidance was for an increase of 30,000 to 50,000. The company also reported second-quarter profit and sales that exceeded analysts' expectations, with adjusted EPS of $6.27, and revenue nearly 10% higher year-over-year to $32.39 billion. Humana credited the results to outperformance at CenterWell on higher-than-anticipated prescription volumes and favorable drug mix, as well as higher insurance revenue as Medicare Advantage membership came in above expectations. Despite today's 5% gains, shares of Humana remain slightly lower year-to-date. Read the original article on Investopedia